Thorough Review of All Costs
First written in FY2017-Q1. 10 of 21 entries say "Restated". Latest entry: FY2026.
90 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The company-wide cost-reduction project, which has made full use of external expertise different from that used in the past, including “cost benchmarks” and “optimal cost-reduction methods,” generated ¥3.7 billion in actual benefits in FY2025, its second year, compared with only ¥900 million in FY2024, when the project began, as the contribution to earnings became more substantial and the initiatives deepened.」
The benefits from the company-wide cost-reduction project increased from ¥900 million in FY2024 to ¥3.7 billion in FY2025. The earnings contribution of the measures, including the use of external expertise, was quantified. - FY2025AdvancedAnnual report
「In FY2024, we achieved approximately ¥1.3 billion in cost reductions, compared with the initial target of ¥1 billion, through lower costs, reduced selling expenses and optimisation of investments. To achieve the final target of ¥10 billion in cost reductions in FY2026, we will continue to apply our execution capabilities and turn them into actual results.」
Regarding the company-wide cost-reduction project, the company achieved approximately ¥1.3 billion in FY2024, exceeding the ¥1 billion target, and indicated that it would continue working toward the final target of ¥10 billion in FY2026. - FY2025-H1Higher fixed costs due to foreign exchange translation effects at overseas subsidiaries and other factorsAnnual report
「In terms of earnings, although higher sales volume and improved terms of trade resulting from yen depreciation had a positive effect, operating income fell to ¥9.385 billion, down ¥1.149 billion year on year, or 10.9%, because fixed costs increased due to foreign exchange translation effects at overseas subsidiaries and other factors,」
Although higher sales volume and improved terms of trade had a positive effect, higher fixed costs due to foreign exchange translation effects at overseas subsidiaries and other factors weighed on operating income. - FY2024AdvancedAnnual report
「Furthermore, with the full commitment of senior management, we will strongly promote a company-wide cost-reduction project.」
The previous cost-reduction policy was given concrete form as a company-wide cost-reduction project backed by the full commitment of senior management. - FY2024-Q3RestatedAnnual report
「In terms of earnings, operating income was ¥12.553 billion, down ¥13.506 billion year on year, or 51.8%, due to lower sales volume of core products and higher costs associated with the shift toward specialty products.」
Higher costs associated with the shift toward specialty products continued to emerge as a factor behind the substantial decline in operating income, together with lower sales volume of core products. - FY2023RestatedAnnual report
「In terms of earnings, although selling prices were revised in response to higher raw material and fuel prices, sales volume declined for some core products, while costs increased as the shift toward specialty products progressed,」
Higher costs associated with the shift toward specialty products continued to be cited, together with lower sales volume of core products, as factors behind the decline in earnings. - FY2023-Q2RestatedAnnual report
「In terms of earnings, operating income was ¥18.308 billion, down ¥6.916 billion year on year, or 27.4%, due to deteriorating terms of trade and higher costs associated with the shift toward specialty products,」
Higher costs associated with the shift toward specialty products continued to be a factor behind the decline in earnings, and operating income fell 27.4% year on year. - FY2023-Q1Higher costs associated with the shift toward specialty productsAnnual report
「In terms of earnings, in addition to deteriorating terms of trade, costs increased as the shift toward specialty products progressed, and operating income was ¥4.902 billion, down ¥2.845 billion year on year, or 36.7%,」
Against the ongoing focus on cost reductions, the company stated that higher costs associated with the shift toward specialty products were a factor behind the decline in earnings this quarter. - FY2021AdvancedAnnual report
「In terms of earnings, operating income rose to ¥34.729 billion, up ¥3.142 billion year on year, or 9.9%, due to growth in high-value-added products for growth fields and reductions in fixed costs, reaching a record high」
The company explained that reductions in fixed costs, together with growth in high-value-added products, contributed to operating income reaching a record high. - FY2021-Q3AdvancedAnnual report
「In terms of earnings, operating income was ¥28.030 billion, up ¥4.006 billion year on year, or 16.7%, due to growth in products in growth fields and reductions in fixed costs.」
The company identified reductions in fixed costs, together with growth in products in growth fields, as factors behind the increase in operating income, indicating the impact of cost-reduction measures in its performance explanation. - FY2019-Q2RestatedAnnual report
「Against this economic backdrop, the Group worked to expand sales in Japan and overseas and reduce costs, focusing on expanding its business and securing earnings.」
The company has reproduced expanded sales in Japan and overseas and cost reductions as ongoing measures. - FY2019-Q1RestatedAnnual report
「Against this economic backdrop, the Group worked to expand sales in Japan and overseas and reduce costs, focusing on expanding its business and securing earnings.」
The company continues to state expanded sales in Japan and overseas and cost reductions as ongoing measures. - FY2018-Q3RestatedAnnual report
「② A thorough review of all costs」
The company continues to pursue a thorough review of all costs as a New Growth Strategy under Denka100. - FY2018-Q2RestatedAnnual report
「② A thorough review of all costs」
The company has reproduced a comprehensive review of costs as one of Denka100’s New Growth Strategies. - FY2018-Q1RestatedAnnual report
「② A thorough review of all costs」
The company has reproduced a comprehensive review of costs as one of Denka100’s 3 New Growth Strategies. - FY2017AdvancedAnnual report
「Major equipment projects completed during the consolidated fiscal year included projects at our Chiba Plant to strengthen competitiveness by optimising utilities, as well as a cost-reduction project for the styrene monomer plant.」
In connection with the comprehensive cost review, the company completed a cost-reduction project for the styrene monomer plant. - FY2017-Q3RestatedAnnual report
「[3 New Growth Strategies] ② A thorough review of all costs」
The company continues to state a comprehensive review of costs as a New Growth Strategy under Denka100. - FY2017-Q2RestatedAnnual report
「[3 New Growth Strategies] ② A thorough review of all costs」
The company continues to state a comprehensive review of costs as a New Growth Strategy under Denka100. - FY2017-Q1First statedAnnual report
「[3 New Growth Strategies] ② A thorough review of all costs」
As a New Growth Strategy under Denka100, the company has established measures for a thorough review of costs.